Compass Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

컴퍼스 테라퓨틱스NASDAQ:CMPX · Nasdaq · Healthcare

$0.8567-4.93%

2026-10-02 close

Compass Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $1M. 2024 operating profit was −$57M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy